Resection of Liver Metastases from an .ALPHA.-fetoprotein-producing Gastric Cancer

Tomohiro Kanda, Hiroshi Yoshida, Yasuhiro Mamada, Nobuhiko Taniai, Youichi Kawano, Yoshiaki Mizuguchi, Tetsuya Shimizu, Tsubasa Takahashi, Junji Ueda, Shunji Kato, Koho Akimaru, Takashi Tajiri, Yuh FukudaJournal of Nippon Medical School 2005 · DOI

Abstract

We describe successful resection of rapidly enlarging liver metastases from an alpha-fetoprotein-producing gastric cancer, as these usually carry a dismal prognosis. A 68-year-old woman underwent distal gastrectomy for an alpha-fetoprotein-producing gastric cancer without liver metastasis. The tumor was a moderately differentiated tubular adenocarcinoma with invasion of the muscularis propria. Venous and lymphatic invasion were noted, as was metastasis to lymph nodes along the greater curvature. Serum alpha-fetoprotein was 331 ng/mL before gastrectomy, decreasing to 18.6 ng/mL by postoperative day 28. At 2 months after operation, computed tomography detected no metastasis, but at 4 months alpha-fetoprotein increased to 2,190 ng/mL, and at 5 months liver tumors were detected by ultrasonography and computed tomography. Serum alpha-fetoprotein increased to 5,673 ng/mL, and serum PIVKA2 concentration was 18 mAU/ml just before operation. Extended left hepatectomy was performed. The resected specimen of segment 4 contained two well-defined tumors, measuring 5 x 4 cm and 2 x 2 cm, while that of segment 5 contained a similar-appearing tumor measuring 2 x 2 cm. The resected tumors had the same histologic appearance as the previously removed gastric cancer. The tumor cells were immunohistochemically reactive for alpha-fetoprotein. The postoperative course was uneventful, and the patient was discharged on postoperative day 15. Serum alpha-fetoprotein decreased to 20 ng/mL by postoperative day 15, and to 5 ng/mL by 2 months after operation. For 5 months since operation, no recurrence has become evident, and serum alpha-fetoprotein has remained within the normal range.

Introduction: The Challenge of AFP-producing Gastric Cancer

Alpha-fetoprotein (AFP)-producing gastric cancer is a rare and highly aggressive subtype of stomach cancer, occurring in only 2% to 6% of cases. While AFP is a common biomarker for hepatocellular carcinoma, its presence in gastric cancer signifies a particularly dangerous clinical profile characterized by high proliferative activity, low apoptosis rates, and a strong affinity for early liver metastasis (occurring in 70% to 80% of cases). Due to the frequent presentation of multiple liver lesions, these tumors are often deemed unresectable, leading to a historically dismal prognosis. This case report challenges that outlook by documenting the successful surgical resection of rapidly growing metachronous liver metastases.

Case Management and Surgical Strategy

A 68-year-old female patient underwent a distal gastrectomy for an AFP-producing gastric cancer. Although initial imaging showed no liver involvement, longitudinal monitoring of serum AFP levels served as a critical lead indicator. While CT scans were initially clear at two months post-operation, a massive spike in AFP levels at four months (reaching 2,190 ng/mL) preceded the radiological detection of tumors.

Computed tomography (CT) scan revealing the presence of liver metastases following the initial gastrectomy.

Once tumors were identified via CT and ultrasonography, the clinical team opted for an aggressive surgical approach: an extended left hepatectomy. This procedure involved the removal of segments 4 and 5 to clear three distinct, well-defined tumor masses, the largest measuring 5x4 cm.

Histopathological and Biochemical Results

The surgical intervention yielded immediate biochemical success. Pre-operative AFP levels of 5,673 ng/mL plummeted to 20 ng/mL by postoperative day 15 and normalized to 5 ng/mL within two months. Histopathological analysis of the resected tissue confirmed that the liver tumors were identical in appearance to the primary gastric cancer.

Histopathological analysis of the resected liver tumors, showing H&E staining (A, C) and immunohistochemical reactivity for alpha-fetoprotein (B, D).

Immunohistochemistry confirmed the "hepatoid" nature of the cells, which mimic liver cells in structure and AFP production. This mimicry explains the aggressive metastatic behavior observed in this subtype. Following the major liver resection, the patient recovered quickly and was discharged on day 15. At a five-month follow-up, she remained recurrence-free with normal AFP levels.

Discussion and Future Outlook

This case highlights two vital clinical insights. First, AFP serves as a more sensitive indicator for recurrence than early-stage imaging in this specific cancer subtype. Second, aggressive surgical resection can be effective even for rapidly enlarging metastases if they are well-defined and the patient has sufficient liver function.

However, limitations remain. This report covers only a five-month post-operative window; longer-term data is necessary to confirm a permanent cure. Additionally, as a single-patient study, these results may not generalize to patients with more diffuse or ill-defined metastatic disease. Future management strategies should likely combine such aggressive surgical interventions with advanced chemotherapy regimens (e.g., 5-fluorouracil or cisplatin) to mitigate the high risk of systemic recurrence.

Summary updated

Abstract

We describe successful resection of rapidly enlarging liver metastases from an alpha-fetoprotein-producing gastric cancer, as these usually carry a dismal prognosis. A 68-year-old woman underwent distal gastrectomy for an alpha-fetoprotein-producing gastric cancer without liver metastasis. The tumor was a moderately differentiated tubular adenocarcinoma with invasion of the muscularis propria. Venous and lymphatic invasion were noted, as was metastasis to lymph nodes along the greater curvature. Serum alpha-fetoprotein was 331 ng/mL before gastrectomy, decreasing to 18.6 ng/mL by postoperative day 28. At 2 months after operation, computed tomography detected no metastasis, but at 4 months alpha-fetoprotein increased to 2,190 ng/mL, and at 5 months liver tumors were detected by ultrasonography and computed tomography. Serum alpha-fetoprotein increased to 5,673 ng/mL, and serum PIVKA2 concentration was 18 mAU/ml just before operation. Extended left hepatectomy was performed. The resected specimen of segment 4 contained two well-defined tumors, measuring 5 x 4 cm and 2 x 2 cm, while that of segment 5 contained a similar-appearing tumor measuring 2 x 2 cm. The resected tumors had the same histologic appearance as the previously removed gastric cancer. The tumor cells were immunohistochemically reactive for alpha-fetoprotein. The postoperative course was uneventful, and the patient was discharged on postoperative day 15. Serum alpha-fetoprotein decreased to 20 ng/mL by postoperative day 15, and to 5 ng/mL by 2 months after operation. For 5 months since operation, no recurrence has become evident, and serum alpha-fetoprotein has remained within the normal range.
BibTeX
@article{kanda2005resection,
  author = {Tomohiro Kanda and Hiroshi Yoshida and Yasuhiro Mamada and Nobuhiko Taniai and Youichi Kawano and Yoshiaki Mizuguchi and Tetsuya Shimizu and Tsubasa Takahashi and Junji Ueda and Shunji Kato and Koho Akimaru and Takashi Tajiri and Yuh Fukuda},
  title = {{Resection of Liver Metastases from an .ALPHA.-fetoprotein-producing Gastric Cancer}},
  journal = {Journal of Nippon Medical School},
  year = {2005},
  doi = {10.1272/jnms.72.66},
}
Figure